Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine

Table 2 ADC, tumor SUVmax and SUV ratio of post TACE viable and nonviable HCC

From: The role of functional imaging; DWI, ADC and 18F-FDG PET/CT in the evaluation of HCC treatment response after transarterial chemoembolization

 

Viable HCC

Nonviable HCC

Value*

p value

Sig.

Mean ± SD

Range

Mean ± SD

Range

ADC (× 10−3 mm2/s)

1.06 ± 0.24

0.58–1.39

1.55 ± 0.33

1.23–2.08

4.677

< 0.001

S

Tumor SUVmax

4.26 ± 0.15

2.4–7.9

2.46 ± 1.05

1.1–3.9

− 3.966

< 0.001

S

SUV ratio

1.42 ± 0.54

1–2.11

0.92 ± 0.26

0.54–1.31

− 3.028

0.005

S

  1. S significant
  2. *Independent sample t test
Back to article page